Luminous Labs FlexCo

Luminous Labs (Graz, Austria, founded 2021) builds precisely dosed red and near-infrared light for female health and longevity.

The dose is what matters: too little light does nothing, too much does less. Our CellLight™ light engine (patent pending, AT A65/2024) covers eight wavelengths from 630 to 1060 nm. OptimalDose™ sets and caps the dose of every programme, the product fixes the distance, and every session on a connected system is logged. The dosing logic draws on our curated research database of 9,452 photobiomodulation papers.

Running in Europe: 17 Redgevity Master systems in 5 countries (Austria, Germany, Switzerland, UK, Ireland), co-developed with our strategic investor and operator Biogena Group · 13,000+ logged sessions · 5,000+ home devices sold, including the Luminous Kini. Research and clinical partners: Politecnico di Milano (tissue optics), Das Kinderwunsch Institut Schenk (Austria) and Fertisuisse (Switzerland).

What we look for in Japan:

· Consumer-health, pharma and trading partners who can bring a wellness device to Japanese customers, and a Japanese importer.

· Research partners on ovarian aging and on measuring light in tissue, including a Japanese co-applicant for FFG Eureka Globalstars Japan.

· Operators (hotels, ryokan, spas, longevity studios) and makers who want our engine inside their products.

· One Japanese strategic investor for our seed extension.

All products are CE-marked wellness devices in Europe (LVD, EMC, RoHS); we make no medical claims. In Japan: wellness first, with a Japanese importer and a regulatory specialist; any medical use only on its own route.

Barbara Sekulovska (CEO) and Thomas Lechner (CTO) attend the Osaka partnering day on 5 October 2026 with the GO TOKYO 2026 delegation and are in Japan until 10 October. Decks (EN/JP): https://drive.google.com/drive/folders/1U_dlJMHVPaV2Q3U7djFjk2bD-JGS4C-U · Research database: https://research-database-two.vercel.app/